Tonix Pharmaceuticals Holding Corp Share Price Nasdaq
Stocks
US8902604094
Pharmaceuticals
| Market Cap | 22Cr 18Cr 17Cr 16Cr 30Cr 2.06TCr 30Cr 203.83Cr 79Cr 1.03TCr 81Cr 79Cr 3.42TCr | P/E 2026 * |
-1.29x | P/E 2027 * | -2.04x |
|---|---|---|---|---|---|
| Enterprise Value | 22Cr 18Cr 17Cr 16Cr 30Cr 2.06TCr 30Cr 203.83Cr 79Cr 1.03TCr 81Cr 79Cr 3.42TCr | EV / Sales 2026 * |
3.84x | EV / Sales 2027 * | 1.85x |
| Free-Float |
99.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tonix Pharmaceuticals Holding Corp
| 1 day | +83.42% |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 16/11/2007 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 01/02/2016 |
Errol Gould
CTO | Chief Tech/Sci/R&D Officer | - | 03/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
David Grange
BRD | Director/Board Member | 78 | 13/02/2018 |
Richard Bagger
BRD | Director/Board Member | 66 | 09/06/2020 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 05/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.42% | -17.57% | - | - | 22Cr | |
| +0.88% | +6.38% | +76.40% | +126.87% | 1,11900Cr | |
| +1.07% | +3.80% | +50.73% | +64.25% | 65TCr | |
| +1.20% | +6.21% | +25.81% | +80.15% | 47TCr | |
| -1.20% | +4.24% | +42.82% | +42.69% | 37TCr | |
| -0.60% | +2.82% | +25.33% | +41.20% | 30TCr | |
| -1.10% | +4.83% | +2.07% | +12.73% | 26TCr | |
| +1.29% | +5.81% | +49.57% | +70.71% | 24TCr | |
| +0.31% | +3.21% | -17.83% | -53.27% | 21TCr | |
| +1.87% | +5.61% | +27.32% | +89.67% | 18TCr | |
| Average | +8.72% | +5.17% | +31.36% | +52.78% | 42.22TCr | |
| Weighted average by Cap. | +0.54% | +5.40% | +44.17% | +72.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.6Cr 4.8Cr 4.49Cr 4.11Cr 7.72Cr 536.16Cr 7.82Cr 53Cr 21Cr 269.34Cr 21Cr 21Cr 890.86Cr | 12Cr 9.95Cr 9.31Cr 8.52Cr 16Cr 1.11TCr 16Cr 109.98Cr 43Cr 558.21Cr 44Cr 43Cr 1.85TCr |
| Net income | -17Cr -14Cr -13Cr -12Cr -23Cr -1.61TCr -23Cr -158.97Cr -62Cr -806.88Cr -63Cr -62Cr -2.67TCr | -15Cr -13Cr -12Cr -11Cr -21Cr -1.46TCr -21Cr -144.73Cr -56Cr -734.58Cr -57Cr -56Cr -2.43TCr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
